- Home
- REAL vs ABCL Comparison
REAL vs ABCL Comparison
Compare REAL & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REAL
- ABCL
- Stock Information
- Founded
- REAL 2011
- ABCL 2012
- Country
- REAL United States
- ABCL Canada
- Employees
- REAL N/A
- ABCL N/A
- Industry
- REAL Other Specialty Stores
- ABCL Biotechnology: Pharmaceutical Preparations
- Sector
- REAL Consumer Discretionary
- ABCL Health Care
- Exchange
- REAL Nasdaq
- ABCL Nasdaq
- Market Cap
- REAL 718.6M
- ABCL 818.2M
- IPO Year
- REAL 2019
- ABCL 2020
- Fundamental
- Price
- REAL $5.50
- ABCL $2.40
- Analyst Decision
- REAL Buy
- ABCL Buy
- Analyst Count
- REAL 6
- ABCL 3
- Target Price
- REAL $8.00
- ABCL $7.00
- AVG Volume (30 Days)
- REAL 3.8M
- ABCL 4.8M
- Earning Date
- REAL 05-06-2025
- ABCL 05-06-2025
- Dividend Yield
- REAL N/A
- ABCL N/A
- EPS Growth
- REAL N/A
- ABCL N/A
- EPS
- REAL N/A
- ABCL N/A
- Revenue
- REAL $600,484,000.00
- ABCL $28,833,000.00
- Revenue This Year
- REAL $11.62
- ABCL $37.12
- Revenue Next Year
- REAL $10.06
- ABCL $41.98
- P/E Ratio
- REAL N/A
- ABCL N/A
- Revenue Growth
- REAL 9.32
- ABCL N/A
- 52 Week Low
- REAL $2.24
- ABCL $2.11
- 52 Week High
- REAL $11.38
- ABCL $4.93
- Technical
- Relative Strength Index (RSI)
- REAL 35.11
- ABCL 38.24
- Support Level
- REAL $4.90
- ABCL $2.11
- Resistance Level
- REAL $5.96
- ABCL $3.01
- Average True Range (ATR)
- REAL 0.50
- ABCL 0.18
- MACD
- REAL -0.04
- ABCL -0.04
- Stochastic Oscillator
- REAL 26.84
- ABCL 31.18
About REAL The RealReal Inc.
The RealReal is the largest pure-play luxury resale platform in the us, generating $1.7 billion in 2023 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 34% of net merchandise value, which excludes returns, cancellations, and first-party sales.
About ABCL AbCellera Biologics Inc.
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.